Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)

2
Delayed Quote. Delayed London Stock Exchange - 04/01 04:25:27 am
46.8875 GBp   +1.38%
03/06 VERNALIS : Gets GBP500,000 Milestone Payment From Asahi Collaboratio..
03/06 VERNALIS : and AKP Achieve Research Milestone
03/06 VERNALIS : and Asahi Kasei Pharma Achieve Research Milestone
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
03/26/2015 03/27/2015 03/30/2015 03/31/2015 04/01/2015 Date
45.5(c) 46.5(c) 45.25(c) 46.25(c) 46.8875 Last
120 966 5 719 37 709 34 310 27 520 Volume
-0.55% +2.20% -2.69% +2.21% +1.38% Change
More quotes
Financials ( GBP)
Sales 2015 18,3 M
EBIT 2015 -15,8 M
Net income 2015 -12,3 M
Finance 2015 23,8 M
Yield 2015 -
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016 -
Capi. / Sales 2015 9,86x
Capi. / Sales 2016 -
Capitalization 205 M
More Financials
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
More about the company
Surperformance© ratings of Vernalis plc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERNALIS PLC
03/06 VERNALIS : Gets GBP500,000 Milestone Payment From Asahi Collaboration
03/06 VERNALIS : and AKP Achieve Research Milestone
03/06 VERNALIS : and Asahi Kasei Pharma Achieve Research Milestone
02/26 VERNALIS : licenses proprietary adenosine receptor antagonist technology, includ..
02/26 VERNALIS : Enters Licence Deal With US-Based Biotechnology Firm
02/26 VERNALIS : Licenses Proprietary ARA Technology
02/10 VERNALIS : Posts Narrowed Loss On Dollar Strength And Lower Costs
02/10 VERNALIS : Unaudited interim results for the periods ended 31 December 2014
More news
Sector news : Biotechnology & Medical Research - NEC
03/31 Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stoc..
03/31 QUEST DIAGNOSTICS : Quintiles, Quest to test lab joint venture for drugmakers
03/31 Intercept Pharmaceuticals Announces Proposed Offering of Common Stock
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF